ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Therapeutic Targeting of the Disrupted Metabolic State in DIPG | University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD | Innovation Grants | 2019 | Michigan |
High-dimensional Biochemical CyTOF Analysis of Pediatric T cell Leukemias | University of California San Francisco / Jeroen Roose, PhD | Innovation Grants | 2015 | California |
In-UTR Mutations in Neuroblastoma: Functional Consequences and Therapeutic Implications | Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko | Innovation Grants | 2010 | Pennsylvania |
Targeting BRD9 in Sarcoma | Dana-Farber Cancer Institute / Scott Armstrong, MD/PhD | Innovation Grants | 2017 | Massachusetts |
Epigenetic Characterization of the Neuroblastoma Driver Genes ARID1A and ARID1B | Children’s Hospital of Philadelphia / Michael Hogarty, MD | Innovation Grants | 2013 | Pennsylvania |
Targeting Neurons in the Osteosarcoma Microenvironment with Non-Opioid Analgesic Lipid Nanoparticles | The Johns Hopkins University School of Medicine / Aaron James, MD, PhD | Innovation Grants | 2023 | Maryland |
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs | University of Alberta / Hasan Uludag, PhD | Innovation Grants | 2019 | Alberta |
Identifying Epigenetic Mechanisms Impacting Neuroblastoma Genome Stability and Drug Response | Massachusetts General Hospital / Johnathan Whetstine, PhD | Innovation Grants | 2015 | Massachusetts |
Identification of New Therapeutic Targets in Pediatric Acute Lymphoblastic Leukemia Through Mosaic Trisomy and Aneuploidy-Based Synthetic Lethality Screens | Dana-Farber Cancer Institute / David Pellman | Innovation Grants | 2010 | Massachusetts |
Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus | Research Institute at Nationwide Children's Hospital / Kevin Cassady, MD & Christopher Walker, PhD | Innovation Grants | 2016 | Ohio |